Non-alcoholic fatty liver disease. change from F3 to F1 fibrosis after 12 months of combined pioglitazone and dulaglutide treatment
L Lener, M Chianelli, F Graziano… - Endocrine …, 2024 - endocrine-abstracts.org
Background: Liver fibrosis is the result of the chronic hepatocyte damage due to different
causes. Among them, Non-alcoholic Fatty Liver Disease (NAFLD) is estimated to account for …
causes. Among them, Non-alcoholic Fatty Liver Disease (NAFLD) is estimated to account for …
[HTML][HTML] Approach to Fatty Liver Disease in Patients with Type 2 Diabetes
JC Bae - The Journal of Korean Diabetes - synapse.koreamed.org
Type 2 diabetes is a major risk factor for development and progression of non-alcoholic fatty
liver disease (NAFLD). Fatty liver is prevalent in people with type 2 diabetes, and overweight …
liver disease (NAFLD). Fatty liver is prevalent in people with type 2 diabetes, and overweight …
[HTML][HTML] The diagnostic and initial approach of the patient with non-alcoholic fatty liver disease: role of the primary care provider
N Salva-Pastor, NC Chávez-Tapia… - … and hepatology from …, 2019 - ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) represents a broad spectrum of liver damage,
ranging from simple steatosis to steatohepatitis and fibrosis; as well, there is a close …
ranging from simple steatosis to steatohepatitis and fibrosis; as well, there is a close …
Non-Alcoholic Fatty Liver Disease.
R Brůha - Vnitrni lekarstvi, 2019 - europepmc.org
Non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of a metabolic
syndrome, is a leading cause of chronic liver disease worldwide with prevalence 17-46% in …
syndrome, is a leading cause of chronic liver disease worldwide with prevalence 17-46% in …
Nonalcoholic fatty liver disease: cause or consequence of insulin resistance?
EE Mishina, AY Mayorov, PO Bogomolov… - Diabetes …, 2017 - dia-endojournals.ru
Nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) are
pathological conditions that are co-occurring, and have been reaching epidemic …
pathological conditions that are co-occurring, and have been reaching epidemic …
[HTML][HTML] The tip of the non‐alcoholic fatty liver disease iceberg—the more we know, the smaller it gets?
S Biswas - JGH Open: an Open Access Journal of …, 2023 - ncbi.nlm.nih.gov
Hepatic steatosis (HS) is defined as an intrahepatic fat content of more than 5%. 1 While the
clinical entity of non-alcoholic fatty liver disease (NAFLD) is based on a diagnosis of …
clinical entity of non-alcoholic fatty liver disease (NAFLD) is based on a diagnosis of …
Clinical diagnosis and evaluation pathway
Nonalcoholic fatty liver disease (NAFLD) is a spectrum of disease ranging from simple
steatosis to nonalcoholic steatohepatitis to advanced fibrosis and cirrhosis. This chapter …
steatosis to nonalcoholic steatohepatitis to advanced fibrosis and cirrhosis. This chapter …
[PDF][PDF] Steatosis affects the sensitivity but not the specificity of non-invasive fibrosis tests in non-alcoholic fatty liver disease-implications for screening strategies
N Zakeri, EA Tsochatzis - Liver International, 2018 - discovery.ucl.ac.uk
The clinical and financial burden of non-alcoholic fatty liver disease (NAFLD) is rising, with a
global prevalence of approximately 25%(1). NAFLD encompasses a wide disease spectrum …
global prevalence of approximately 25%(1). NAFLD encompasses a wide disease spectrum …
Diagnosis of non-alcoholic fatty liver disease (NAFLD)
H Yki-Järvinen - Diabetologia, 2016 - Springer
Non-alcoholic fatty liver disease (NAFLD) increases risk of mortality from liver and
cardiovascular disease (CVD) and is the major cause of hepatocellular carcinoma (HCC) …
cardiovascular disease (CVD) and is the major cause of hepatocellular carcinoma (HCC) …
Non-alcoholic fatty liver disease in patients with type 2 diabetes: evaluation of hepatic fibrosis and steatosis using fibroscan
Patients with type 2 diabetes mellitus (T2DM) are at increased risk of non-alcoholic fatty liver
disease (NAFLD) and might eventually progress to advanced fibrosis, cirrhosis and …
disease (NAFLD) and might eventually progress to advanced fibrosis, cirrhosis and …